about
Evaluation of clonal origin of malignant mesotheliomaHigh incidence of somatic BAP1 alterations in sporadic malignant mesotheliomaRanpirnase Interferes with NF-κB Pathway and MMP9 Activity, Inhibiting Malignant Mesothelioma Cell Invasiveness and Xenograft GrowthFibulin-3 as a blood and effusion biomarker for pleural mesothelioma.Germline BAP1 mutations predispose to malignant mesotheliomaCrocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamstersConsensus report of the 2015 Weinman International Conference on MesotheliomaSoluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusionsIncreased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapyRecent insights emerging from malignant mesothelioma genome sequencingTNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesisMalignant mesothelioma: facts, myths, and hypothesesCellular and molecular parameters of mesotheliomaThe Presence of Asbestos in the Natural Environment is Likely Related to Mesothelioma in Young Individuals and Women from Southern NevadaHigh-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesotheliomaCombined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700sMolecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesotheliomaBAP1 hereditary cancer predisposition syndrome: a case report and review of literatureLosses of both products of the Cdkn2a/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis
P50
Q21146661-CE4A6241-AAA3-48C4-8414-1D3FE0090710Q24170431-BD54C7D2-9AF5-4022-8B6F-B8D7AECD241FQ24612464-D61F2F41-959F-480C-BCD3-3AC33C806F3AQ24628879-B935AD77-F0FC-4CF5-A06E-FF5D00DC98DCQ24635326-4B21CD32-5DBE-40E9-9A07-3B4EF526CE21Q24676844-2F22C156-3F85-452B-B647-D6A48B400C7AQ27908468-423E105A-4659-44A0-A3F8-D9D804427C48Q28262540-0FC90E1F-A7D3-439F-819C-EEC678A5D4A5Q28385656-F275D738-ECAA-4769-9214-A2B5E9F92B59Q28388301-20F8CCAF-C904-42CE-BCA7-5909710362D9Q28389414-6FF5E6B8-37A0-4CE7-9A5F-B8364266DEBEQ28390539-628AA6D7-9BA3-4611-9D07-F5DE2C5196F4Q28391676-24116C36-F972-4217-A733-2AB84FBF3DCCQ28392367-0B238D8B-9C60-4700-B50E-22F6F18FAB6CQ28395181-64D953C3-C253-4A92-900E-10DC916DAE53Q28396964-B3B8CE9B-1D03-4124-A2AB-509283EDB4D6Q28397153-35EFD70B-D5FC-4B3D-9D39-525E93933417Q28397624-2136196F-EB41-4FF9-97C8-B50358785F84Q28740925-985A9EEF-7E9E-47AD-9DF4-B4D8B491FD4A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michele Carbone
@ast
Michele Carbone
@en
Michele Carbone
@es
Michele Carbone
@nl
Michele Carbone
@sl
type
label
Michele Carbone
@ast
Michele Carbone
@en
Michele Carbone
@es
Michele Carbone
@nl
Michele Carbone
@sl
prefLabel
Michele Carbone
@ast
Michele Carbone
@en
Michele Carbone
@es
Michele Carbone
@nl
Michele Carbone
@sl
P1006
P214
P244
P1006
P106
P213
0000 0000 3982 0410
P214
P244
n2005183543
P31
P7859
lccn-n2005183543